EU Launches Safety Review Of Finasteride And Dutasteride Over Suicidal Thoughts And Behavior

 
• By Ian Schofield

France’s regulatory agency, which triggered the review, says it believes that the addition of suicidal ideation to the product information for finasteride and reports of cases of completed suicide “seriously alter” the product’s benefit-risk profile. 

Businessman showing risk level indicator rating since low to high for risk management and assessment review concept
The EU is weighing the risks of two 5-alpha reductase inhibitors • Source: Shutterstock

More from Europe

More from Geography